Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | NN3201 |
Synonyms | |
Therapy Description |
NN3201 is an antibody-drug conjugate (ADC) comprising an antibody targeting KIT linked to monomethyl auristatin E (MMAE), which potentially induces cytotoxicity against KIT-expressing tumor cells and inhibits tumor growth (Cancer Res (2024) 84 (6_Supplement): 3142). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
NN3201 | NN 3201|NN-3201 | NN3201 is an antibody-drug conjugate (ADC) comprising an antibody targeting KIT linked to monomethyl auristatin E (MMAE), which potentially induces cytotoxicity against KIT-expressing tumor cells and inhibits tumor growth (Cancer Res (2024) 84 (6_Supplement): 3142). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
KIT positive | lung small cell carcinoma | predicted - sensitive | NN3201 | Preclinical - Cell line xenograft | Actionable | In a preclinical study, NN3201 induced cytotoxicity and cell cycle arrest in KIT-positive small cell lung cancer cell lines in culture, and inhibited tumor growth in a cell line xenograft model (Cancer Res (2024) 84 (6_Supplement): 3142). | detail... |
KIT positive | gastrointestinal stromal tumor | predicted - sensitive | NN3201 | Preclinical - Cell line xenograft | Actionable | In a preclinical study, NN3201 induced cytotoxicity and cell cycle arrest in KIT-positive gastrointestinal stromal tumor cell lines in culture, and inhibited tumor growth in a cell line xenograft model (Cancer Res (2024) 84 (6_Supplement): 3142). | detail... |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|